Gordian Biotechnology

After years of hype, AI-designed drugs are falling short in the clinic. Why? For AI to succeed in drug discovery, training data must come from living mammals. While efficacy and safety must be validated in a living organism (in vivo), cost and efficiency has forced drug discovery to seek out simplified systems to run tests at scale. This means drug discovery models are being trained in the wrong system. You don’t train a self-driving car on the California Vehicle Code, you train it on the road. If you’re going to test your drug in a living mammal, you must train for discovery in that living mammal. Read the full post here: https://lnkd.in/e9uKdvUq

Big (and belated) congratulations to Alex Araki! Previously a research associate on the in vivo team, Alex has successfully defended his thesis and earned a well-deserved promotion to scientist! Traditionally, securing a scientist title usually requires a PhD. But at Gordian, we believe that allowing talented and deserving researchers like Alex to contribute on the same level without having to pause their careers to go back to school will advance our mission and offer enrichment and opportunity that wouldn’t be available academically. We’re so proud of Alex and excited to see all the amazing work he’ll do in this next chapter! #CareerGrowth  #Biotech  #InVivoResearch

Gordian Biotechnology needs your help to cure age-related disease! #Hiring ex vivo scientists: Pooled in vivo screening is showing us a lot of targets with efficacy in multiple age-related diseases. Next up is confirming this in vivo efficacy in patient samples. But our team can't keep up with all the screen hits. So we're #hiring for two roles in SF: Both are scientists working hands-on with complex ex vivo systems, e.g. tissue explants and precision-cut slices. The more senior role will also bring industry experience to guide the ex vivo team with best practices and mentor junior colleagues. Apply here: https://lnkd.in/gwFgvT3T Read more about our science: https://lnkd.in/gqbW7_zY, and company/culture: https://lnkd.in/gHCJn9hy #biotech #sanfrancisco #bayarea #startupjobs #drugdiscovery #heartfailure #osteoarthritis #aging #creatingtime

ICYMI, co-founders Francisco LePort and Martin Borch Jensen were guests of Dr. Moira Gunn on the BioTech Nation podcast. It ran on our hometown NPR station KQED and about 200 other NPR affiliates.

If you don’t already subscribe to the BioTech Nation podcast with Moira Gunn, you will now! The latest episode dropped today, featuring co-founders Francisco LePort and Martin Borch Jensen discussing how Gordian’s high-throughput in vivo screening platform will transform drug discovery for age-related disease. It’s exciting to hear about complex scientific topics in such a high-energy, accessible conversation. Big thanks to the always-captivating Dr. Gunn and her crew!

This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology discuss their innovative approach to treating diseases of aging. By testing hundreds of treatments at the same time, they aim to find the most effective ones faster.  Listen now: https://lnkd.in/gjRkszBc

This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology discuss their innovative approach to treating diseases of aging. By testing hundreds of treatments at the same time, they aim to find the most effective ones faster.  Listen now: https://lnkd.in/gjRkszBc

Gordian Biotechnology needs your help to cure age-related disease! #Hiring ex vivo scientists: Pooled in vivo screening is showing us a lot of targets with efficacy in multiple age-related diseases. Next up is confirming this in vivo efficacy in patient samples. But our team can't keep up with all the screen hits. So we're #hiring for two roles in SF: Both are scientists working hands-on with complex ex vivo systems, e.g. tissue explants and precision-cut slices. The more senior role will also bring industry experience to guide the ex vivo team with best practices and mentor junior colleagues. Apply here: https://lnkd.in/gwFgvT3T Read more about our science: https://lnkd.in/gqbW7_zY, and company/culture: https://lnkd.in/gHCJn9hy #biotech #sanfrancisco #bayarea #startupjobs #drugdiscovery #heartfailure #osteoarthritis #aging #creatingtime

Join us for an unforgettable conversation on the future of aging biology! On January 28, 2025, we’re kicking off Nucleate: Inside Aging with a free virtual opening session featuring two pioneering leaders in aging biology and longevity biotech: 🎙 Eric Verdin , PhD President & CEO of the Buck Institute for Research on Aging 🎙 Martin Borch Jensen, PhD Co-Founder of Gordian Biotechnology & President of Norn Group 🕛 When: 12 PM Eastern 📍 Where: Virtual (link to register below) These world-renowned experts will dive into the current landscape of aging research, where the field is headed, and—most importantly—how you can get involved in advancing healthier, longer lives. This is a must-attend event for: ▫️ Graduate students passionate about biotechnology ▫️ Investors exploring opportunities in longevity innovation ▫️ Anyone curious about the science transforming our understanding of aging. 💡 Don’t miss out—register now at https://lu.ma/ej49cnxn 💡 Let’s shape the future of aging biology together. Join us on January 28th! #AgingBiology #LongevityBiotech #AgingResearch #Innovation #NucleateInsideAging #VirtualWebinar #Biotechnology

Why is it tough to run scientific trials for longevity? Find out how the incentive structures & timescales make this a challenge... and discover how we can work toward more direct results on this week's Inner Cosmos with longevity expert Martin Borch Jensen. eagleman.com/podcast/81 #brain #longevity